ADMA Biologics Inc · NASDAQ:ADMA
Grossman Adam S sold 147,000 ADMA Biologics Inc shares (Form 4)
Traded Nov 5, 2026 · Filed Nov 5, 2026
On Nov 5, 2026, Grossman Adam S (Director, President and CEO) sold 147,000 ADMA Biologics Inc shares at US$12.00 for US$1.76M under a trading plan, leaving 2,070,777 shares. Filed Nov 5, 2026 (Form 4).
- Sold
- 147,000 shares
- Price
- US$12.00
- Value
- US$1.76M
- Holding after
- 2,070,777 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, President and CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 5, 2026 | Common Stock | Option exercise | 105,000 | US$5.40 | 2,217,777 | Direct |
| Nov 5, 2026 | Common Stock | Sale | 105,000 | US$12.00 | 2,112,777 | Direct |
| Nov 5, 2026 | Common Stock | Sale | 42,000 | US$12.00 | 2,070,777 | Direct |
Source
Download original · View original at SEC
Related
- ADMA Biologics Inc
- Grossman Adam S
- ADMA Biologics Inc shareholders
- Form 4 · Grossman Adam S · Nov 16, 2026
- Form 4 · Guiheen Lawrence P. · Nov 16, 2026
- Schedule 13G · Rubric Capital Management LP · Nov 16, 2026
- Schedule 13G · State Street Corp · Nov 10, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Form 4 · Kestenberg-Messina Kaitlin M. · Jul 28, 2026